NEXOBRID

Peak

anacaulase-bcdb

BLATOPICALGEL
Approved
Dec 2022
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
3

Mechanism of Action

eschar. The specific components responsible for this effect have not been identified.

Clinical Trials (3)

NCT02148705Phase 3Completed

A Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal Burns

Started May 2015
175 enrolled
Thermal Burns
NCT02278718Phase 3Completed

A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard of Care

Started May 2015
145 enrolled
Thermal Burns
NCT04040660N/AApproved For Marketing

Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries

Thermal Burn